4RVJ
Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with amprenavir
Summary for 4RVJ
Entry DOI | 10.2210/pdb4rvj/pdb |
Related | 4HLA 4NJS 4NJT 4NJU 4NJV 4RVI 4RVV 4RVX |
Descriptor | HIV-1 protease, {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER (3 entities in total) |
Functional Keywords | hiv-1 protease-inhibitor complex, amprenavir, non-peptidic protease inhibitor, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Human immunodeficiency virus 1 |
Total number of polymer chains | 4 |
Total formula weight | 44466.25 |
Authors | Yedidi, R.S.,Garimella, H.,Kaufman, J.D.,Das, D.,Wingfield, P.T.,Mitsuya, H. (deposition date: 2014-11-26, release date: 2016-05-04, Last modification date: 2024-02-28) |
Primary citation | Yedidi, R.S.,Maeda, K.,Aoki, M.,Garimella, H.,Rao, K.V.,Akasapu, S.,Davis, D.A.,Kaufman, J.D.,Das, D.,Wingfield, P.T.,Amano, M.,Ghosh, A.K.,Mitsuya, H. Enhanced antiviral activity by the P2-tris-tetrahydrofuran moiety of GRL-0519, a novel nonpeptidic HIV-1 protease inhibitor (PI), against multi-PI-resistant and highly darunavir-resistant strains of HIV-1 To be Published, |
Experimental method | X-RAY DIFFRACTION (1.6 Å) |
Structure validation
Download full validation report